APA (7th ed.) Citation

Yanagida, K., Kawai, T., Seito, T., Matsumoto, K., Kaneko, T., & Nakagawa, T. (2024). Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma. Wiley.

Chicago Style (17th ed.) Citation

Yanagida, Kazuki, Taketo Kawai, Toyoshi Seito, Kensuke Matsumoto, Tomoyuki Kaneko, and Tohru Nakagawa. Myelodysplastic Syndrome Occurring After Enfortumab Vedotin Treatment for Metastatic Urothelial Carcinoma. Wiley, 2024.

MLA (9th ed.) Citation

Yanagida, Kazuki, et al. Myelodysplastic Syndrome Occurring After Enfortumab Vedotin Treatment for Metastatic Urothelial Carcinoma. Wiley, 2024.